Revolutionary drug can slash risk of women with the 'Angelina Jolie gene' dying of breast cancer - Daily Mail

A team of UK and US researchers studied 2,000 women with BRCA1 and BRCA2 early-stage cancer and gave half of them tablets of olaparib twice a day for a year.

A revolutionary drug can drastically slash the risk of women with the 'Angelina Jolie gene' dying from breast cancer. Scientists studied nearly 2,000 women with early-stage cancer, all of whom had t… [+5754 chars]

full article...